Glucagon-like peptide-1 receptor agonist use and clinical outcomes after lung transplantation: A single-center cohort study

In this small, retrospective cohort with limited GLP-1 RA exposure, GLP-1 RA use before and early after transplantation was not associated with worse early or late outcomes, including CLAD and mortality, and was generally well tolerated. These results are reassuring but should be interpreted cautiously; prospective studies in larger cohorts are needed to confirm safety and to define optimal patient selection and timing.